Aspirin and Clampsilin for Preeclampsia Treatment
Author Information
Author(s): Kostadinova-Slavova Denitsa, Petkova-Parlapanska Kamelia, Koleva Irina, Angelova Mariya, Sadi J. Al-Dahwi Rafaah, Georgieva Ekaterina, Karamalakova Yanka, Nikolova Galina, Chazot Paul L.
Primary Institution: Medical Faculty, Trakia University
Hypothesis
The study aimed to investigate and compare oxidative stress biomarkers and antioxidant enzyme activity in women at risk of developing preeclampsia.
Conclusion
Oxidative stress in preeclampsia plays a key role, and aspirin therapy is more effective than Clampsilin in preventing complications.
Supporting Evidence
- Pregnant women at risk of preeclampsia had significantly higher levels of oxidative stress markers compared to normal pregnancies.
- Low-dose aspirin therapy is associated with a reduction in the incidence of preeclampsia.
- Oxidative stress in preeclampsia is linked to placental problems affecting both mother and baby.
Takeaway
This study looked at how aspirin can help pregnant women at risk of a condition called preeclampsia, which can be harmful to both moms and babies.
Methodology
The study measured levels of oxidative stress markers and antioxidant enzyme activity in the serum of pregnant women at risk of preeclampsia.
Potential Biases
Potential biases may arise from the selection of participants and the methods of measuring biomarkers.
Limitations
The study was limited to a specific population and may not be generalizable to all pregnant women.
Participant Demographics
Pregnant women aged 28 ± 8 years, with a focus on those at high and moderate risk of preeclampsia.
Statistical Information
P-Value
p<0.03
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website